Piper Sandler Downgrades Deciphera (DCPH) to Neutral, Following Clinical Business Update
Tweet Send to a Friend
Piper Sandler analyst Christopher Raymond downgraded Deciphera (NASDAQ: DCPH) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
